.

About the Study

Thank you for your interest in the CEASAR Study.  CEASAR (Comparative Effectiveness Analysis of Surgery and Radiation) is a multi-site research program that has enrolled more than 3,600 men with a diagnosis of localized prostate cancer.  The study began in 2010, and is funded and coordinated through Vanderbilt University, in Nashville, Tennessee.  CEASAR includes participants enrolled from the following six sites:

Three rounds of surveys have so far been completed: baseline survey at time of diagnosis; 6-month follow-up; and 12-month follow-up.  The three-year follow-up survey started in March of 2014, and will continue through the end of the year.

Our ongoing goal for CEASAR is to help learn more about what treatment works best, for which patients, in whose hands.  To learn more about the current status of the CEASAR Study, please click here to view our March 2014 CEASAR Newsletter.

Copies of the CEASAR surveys are available here:

CEASAR Baseline Survey

CEASAR Baseline Survey (Spanish language version)

CEASAR Six Month Follow-up Survey

CEASAR Six Month Follow-up Survey (Spanish language version)

CEASAR Twelve Month Follow-up Survey

CEASAR Twelve Month Follow-up Survey (Spanish language version)

CEASAR Three Year Follow-up Survey

CEASAR Three Year Follow-up Survey (Spanish language version)

 

This page was last updated May 30, 2014 and is maintained by